Drug Trial Radar · NCT04684602
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Last checked: Nov 19, 2026Latest source record: Apr 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
5,000
Planned (sponsor's estimate)
Start
Jul 9, 2020
Primary completion
Jul 9, 2030
Study completion Dec 9, 2030
Sponsor
- Lead sponsor
- Thomas Advanced Medical LLCIndustry
- Sponsor type
- Industry
- Collaborators
- HeartStem Institute; NuStem
- First posted
- Dec 24, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.
Conditions
- Autoimmune Diseases
- Cardiovascular Disorders
- Diabetes Complications
- Integumentary Disease
- Musculoskeletal Disorders
- Neurodegenerative Disorders
- Neurologic Disorders
- Pulmonary Disorders
- Sexual Dysfunction
- Urologic Disorders
- Viral Illness
Interventions
PrimePro™/ PrimeMSK™Biological
Injection via condition specific route of administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of quality of life (QOL) via 36-Item Short Form Survey (SF-36) change from baseline at 6 and 12 months.Time frame: Follow up time-frames will measure changes occurring from baseline post procedure at 6 months and 12 months.
- Assessment of disabilities of arm, shoulder, hand via DASH Questionnaire change from baseline at 6 and 12 months.Time frame: Follow up time-frames will measure changes occurring from baseline post procedure at 6 months and 12 months.
- Assessment of erectile function via International Index of Erectile Function (IIEF-5) change from baseline at 6 and 12 months.Time frame: Follow up time-frames will measure changes occurring from baseline post procedure at 6 months and 12 months.
- Assessment of COPD via Clinical Chronic Obstructive Pulmonary Disease Questionnaire change from baseline at 6 and 12 months.Time frame: Follow up time-frames will measure changes occurring from baseline post procedure at 6 months and 12 months.
- Assessment of mental state via Mini Mental State Examination (MMSE) change from baseline at 6 and 12 months.Time frame: Follow up time-frames will measure changes occurring from baseline post procedure at 6 months and 12 months.
- Assessment of interstitial cystitis via O'Leary/Sant Questionnaire change from baseline at 6 and 12 months.Time frame: Follow up time-frames will measure changes occurring from baseline post procedure at 6 months and 12 months.
- Assessment of back pain via Oswestry Low Back Pain Disability Questionnaire change from baseline at 6 and 12 months.Time frame: Follow up time-frames will measure changes occurring from baseline post procedure at 6 months and 12 months.
- Assessment of osteoarthritis via Western Ontario and McMaster Osteoarthritis Index (WOMAC) change from baseline at 6 and 12 months.Time frame: Follow up time-frames will measure changes occurring from baseline post procedure at 6 months and 12 months.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites
Culver City, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.